Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Mild Cognitive Impairment caused by Alzheimer's disease
- People who have been diagnosed with Dementia with Lewy Bodies
- People who have been diagnosed with Frontotemporal dementia
- People who have been diagnosed with Idiopathic Normal Pressure Hydrocephalus (a condition where fluid builds up in the brain for no known reason)
Who may not be able to join:
- People who have a history of seizures (epilepsy or similar episodes)
- People who are pregnant
- People who have metal implants in the head, not including standard dental fillings
- People who have an electronic implant in their body, such as a pacemaker or an implanted medical pump
- People who are under 18 years of age
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Eino Solje, MD, PhD, Kuopio University Hospital
Phone: +358 17 713 311
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in Rey Auditory Verbal Learning Test score; Changes in Rey Auditory Verbal Learning Test, recognition; Changes in orientation to time and place (MMSE questions 1-10); Changes in Trail Making A & B tests; Changes in INECO Frontal Screening test; Changes in phonemic fluency
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.